Valsartan — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

4 Completed trials

10 Sponsors

13 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 2 Phase II: 1 Phase III/IV: 1 Phase IV: 6

Oversight events:

9 temporary halts 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Arterial tortuosity syndrome 1 Loeys-Dietz syndrome 1 Hypertrophic cardiomyopathy 1 Focal segmental glomerulosclerosis 1 Shprintzen-Goldberg syndrome 1 Ehlers-Danlos syndrome 1 Marfan's syndrome 1

Sponsors using this IMP

Andrea Di Marco 1 Bellvitge University Hospital 1 Dimerix Bioscience Pty Limited 1 Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia 1 Medical University Of Gdansk 1 Medical University Of Graz 1 Medical University Of Vienna 1 Novartis Pharma AG 1 Policlinico San Donato S.p.A. 1 University Hospital Maastricht 1

All trials

10 total

Prevention of heart disease in heart-healthy patients with diabetes based on a special parameter (NT-proBNP) Pending

2024-519051-28-01 Phase IV 2 countries Medical University Of Vienna
Pharmacological optimization in prevention in Heart Failure: A Sex-gap? Recruiting

2025-520660-18-00 Phase IV 1 country Policlinico San Donato S.p.A.
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
HYDrochlorothiazidE compared to valsartan to treat arterial hypertension in patients with Hypertrophic obstructive CardioMyopathy – the HYDE… Recruiting

2024-520086-31-00 Phase IV 1 country Medical University Of Graz
TREASURE trial Recruiting

2022-503135-33-00 Phase IV 1 country University Hospital Maastricht
Evaluation of the Efficacy of Valsartan in Slowing Down Aortic Root Dilatation in Children and Young Adults with Marfan Recruiting

2024-515059-39-00 Phase III 1 country Medical University Of Gdansk
VALSARTAN TREATMENT COMPARED IN RENAL TRANSPLANT RECIPIENTS WITH SIGNS OF POST TRANSPLANT GLOMERULOPATHY Ended

2024-518723-30-01 Phase IV 1 country Bellvitge University Hospital
Efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis Ended

2023-504597-37-00 Phase III 7 countries Dimerix Bioscience Pty Limited
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE) Ended

2023-504946-70-00 Phase IV 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Phase II 11 countries Novartis Pharma AG

Showing 1–10 of 10 trials

← All drugs A–Z